Effectiveness of Tumor Necrosis Factor [alpha] Blockers in Early Axial Spondyloarthritis: Data From the DESIR Cohort

Objective To estimate the frequency of use and effectiveness in daily practice of tumor necrosis factor [alpha] (TNF[alpha]) blockers in a population with inflammatory back pain suggestive of early axial spondyloarthritis (SpA). Methods The Devenir des Spondylarthropathies Indifférenciées Récentes (...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2014-07, Vol.66 (7), p.1734
Main Authors: Molto, Anna, Paternotte, Simon, Claudepierre, Pascal, Breban, Maxime, Dougados, Maxime
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To estimate the frequency of use and effectiveness in daily practice of tumor necrosis factor [alpha] (TNF[alpha]) blockers in a population with inflammatory back pain suggestive of early axial spondyloarthritis (SpA). Methods The Devenir des Spondylarthropathies Indifférenciées Récentes (DESIR) cohort is a prospective, multicenter, observational cohort of 708 patients with early (
ISSN:2326-5191
2326-5205
DOI:10.1002/art.38613